title: Simulation modeling of pooling for combinatorial protein engineering.
abstract: Pooling in directed-evolution experiments will greatly increase the throughput of screening systems, but important parameters such as the number of good mutants created and the activity level increase of the good mutants will depend highly on the protein being engineered. The authors developed and validated a Monte Carlo simulation model of pooling that allows the testing of various scenarios in silico before starting experimentation. Using a simplified test system of 2 enzymes, betagalactosidase (supermutant, or greatly improved enzyme) and beta-glucuronidase (dud, or enzyme with ancestral level of activity), the model accurately predicted the number of supermutants detected in experiments within a factor of 2. Additional simulations using more complex activity distributions show the versatility of the model. Pooling is most suited to cases such as the directed evolution of new function in a protein, where the background level of activity is minimized, making it easier to detect small increases in activity level. Pooling is most successful when a sensitive assay is employed. Using the model will increase the throughput of screening procedures for directed-evolution experiments and thus lead to speedier engineering of proteins.
authors.affiliation: School of Chemical & Biomolecular Engineering, Georgia Institute of Technology, Atlanta 30332-0100, USA.
authors.forename: Karen M
authors.initials: KM
authors.lastname: Polizzi
authors.forename: Cody U
authors.initials: CU
authors.lastname: Spencer
authors.forename: Anshul
authors.initials: A
authors.lastname: Dubey
authors.forename: Ichiro
authors.initials: I
authors.lastname: Matsumura
authors.forename: Jay H
authors.initials: JH
authors.lastname: Lee
authors.forename: Matthew J
authors.initials: MJ
authors.lastname: Realff
authors.forename: Andreas S
authors.initials: AS
authors.lastname: Bommarius
mesh_terms: D002478:Cells, Cultured; D003198:Computer Simulation; D019020:Directed Molecular Evolution; D004353:Drug Evaluation, Preclinical / Q000379:methods*; D008954:Models, Biological; D009010:Monte Carlo Method; D015202:Protein Engineering; D012984:Software; D046888:Tissue Array Analysis